seizures
-
FDA Clearance Spotlight: Ceribell
Ceribell Inc., based in Sunnyvale, California, has developed a point-of-care EEG system that provides real-time seizure monitoring and alerting, which helps in the rapid and precise treatment of patients with suspected non-convulsive seizures. The FDA-cleared Ceribell ClarityPro software uses a machine-learning model to analyze EEG signals and generate bedside alerts.
-
GW Pharmaceuticals gets first FDA approval for CBD-based drug
The FDA approved the cannabis-based drug for treating seizures in two severe forms of epilepsy.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Health IT, Devices & Diagnostics
A wearable using AI to identify severe seizures and warn caregivers gains FDA approval
By passively collecting seizure data, Empatica’s device could help patients share medical information with clinicians and make that data easier to manage.